Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,785,438
-
Share change
-
+1,567,728
-
Total reported value
-
$210,439,000
-
Put/Call ratio
-
58%
-
Price per share
-
$8.16
-
Number of holders
-
65
-
Value change
-
+$25,429,358
-
Number of buys
-
43
-
Number of sells
-
19
Institutional Holders of MARINUS PHARMACEUTICALS INC - COM (MRNS) as of Q4 2017
As of 31 Dec 2017,
MARINUS PHARMACEUTICALS INC - COM (MRNS) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,785,438 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, JENNISON ASSOCIATES LLC, Granite Point Capital Management, L.P., FRANKLIN RESOURCES INC, Vanguard Group Inc, CITADEL ADVISORS LLC, ASCEND CAPITAL, LLC, Balyasny Asset Management LLC, NEXTHERA CAPITAL LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.